Financial Disclosure Statement

Nicola Zamboni
ETH Zurich

MSACL 2015 US Abstract Title:
Metabolomics by Masses, Metabolomics for the Masses

DescriptionY/NSource
GrantsyesAstraZeneca, UK; Beiersdorf, DE
Salaryno
Board MemberyesGeneral Metabolics
Stockno
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no